Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Aim of the study is to better characterize the clinical profile of adjunctive cenobamate by collecting data from the current standard clinical practice in France, Germany, and Spain, to describe the real-world clinical response among adult patients affected by focal epilepsy not adequately controlled despite a history of 2 or 3 ASMs before starting treatment with cenobamate (including previous and concomitant ASMs).

NCT Number	NCT06716801
Lead Sponsor	Aziende Chimiche Riunite Angelini Francesco S.p.A Collaborators: IQVIA Pty Ltd
Conditions	Focal Epilepsy With and Without Secondary Generalization
Enrollment	300 participants
Start Date	2024-12-19
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-09-19